|
Amikacin |
|---|---|
| Trade Name | Arikace |
| Orphan Indication | Bronchopulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients |
| USA Market Approval | USA |
| USA Designation Date | 2006-03-09 00:00:00 |
| Sponsor | Insmed, Inc.;Princeton Corporate Plaza, 9 Deer Park Drive, Suite C;Monmouth Junction, NJ, 08852-1923 |
